ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 81052 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 81052; 2) Community: the network communities that were significantly associated with the response to NSC 81052; 3) Molecule: the relationships between components within communities and NSC 81052; 4) MDR: the compounds that were significantly associated with the NSC 81052.

NSC Compound Enrichment Correlation
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.00286159651545682 0.59987662
NSC 709100 Null 0.00286159651545682 0.34077677
NSC 709564 Null 0.00286159651545682 0.39850772
NSC 720326 2-(5,6,7-Trimethoxyindol-2-carbonyl)amino-4H-pyrazolo[1,5-a] indole 0.00286159651545682 0.41751304
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.00286159651545682 0.41145693
NSC 143019 METHANEDIAMINE, N,N'-BIS(1,3,4-THIADIAZOL-2-YL)- 0.00311117111817091 -0.10288906
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.00311117111817091 0.41382028
NSC 333054 Adriamycin, tetrahydropyranyl 0.00311117111817091 0.27414265
NSC 373355 Saframycin R 0.00311117111817091 0.44725466
NSC 48229 Null 0.00311117111817091 -0.24265601
Total:99  Current:14    [First] [Prev] [Next] [Last]